Samlyn Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-537,888
| Closed | -$25M | – | 112 |
|
|
2022
Q3 | $25M | Buy |
537,888
+75,073
| +16% | +$3.49M | 0.47% | 57 |
|
|
2022
Q2 | $26.4M | Sell |
462,815
-21,288
| -4% | -$1.22M | 0.53% | 48 |
|
|
2022
Q1 | $29.6M | Sell |
484,103
-625,752
| -56% | -$38.3M | 0.43% | 57 |
|
|
2021
Q4 | $58.1M | Sell |
1,109,855
-153,861
| -12% | -$8.05M | 0.8% | 34 |
|
|
2021
Q3 | $47.1M | Buy |
1,263,716
+136,101
| +12% | +$5.07M | 0.63% | 41 |
|
|
2021
Q2 | $46M | Sell |
1,127,615
-241,991
| -18% | -$9.88M | 0.68% | 42 |
|
|
2021
Q1 | $46.5M | Sell |
1,369,606
-290,332
| -17% | -$9.85M | 0.64% | 43 |
|
|
2020
Q4 | $52.8M | Sell |
1,659,938
-72,427
| -4% | -$2.3M | 0.76% | 39 |
|
|
2020
Q3 | $44.5M | Buy |
1,732,365
+553,798
| +47% | +$14.2M | 0.8% | 43 |
|
|
2020
Q2 | $30.3M | Buy |
1,178,567
+25,171
| +2% | +$646K | 0.56% | 54 |
|
|
2020
Q1 | $17.7M | Buy |
1,153,396
+886,696
| +332% | +$13.6M | 0.45% | 55 |
|
|
2019
Q4 | $9.15M | Sell |
266,700
-912,983
| -77% | -$31.3M | 0.19% | 78 |
|
|
2019
Q3 | $8.81M | Buy |
1,179,683
+147,578
| +14% | +$1.1M | 0.21% | 66 |
|
|
2019
Q2 | $13.4M | Sell |
1,032,105
-330,981
| -24% | -$4.3M | 0.28% | 69 |
|
|
2019
Q1 | $16.6M | Buy |
1,363,086
+96,948
| +8% | +$1.18M | 0.39% | 62 |
|
|
2018
Q4 | $14.4M | Buy |
1,266,138
+494,918
| +64% | +$5.64M | 0.34% | 66 |
|
|
2018
Q3 | $16.7M | Sell |
771,220
-219,061
| -22% | -$4.75M | 0.38% | 78 |
|
|
2018
Q2 | $17.5M | Buy |
990,281
+335,938
| +51% | +$5.94M | 0.41% | 72 |
|
|
2018
Q1 | $13.8M | Sell |
654,343
-350,413
| -35% | -$7.38M | 0.3% | 75 |
|
|
2017
Q4 | $14.5M | Buy |
1,004,756
+255,077
| +34% | +$3.69M | 0.33% | 66 |
|
|
2017
Q3 | $11.8M | Buy |
749,679
+212,479
| +40% | +$3.35M | 0.3% | 67 |
|
|
2017
Q2 | $6.67M | Buy |
537,200
+198,700
| +59% | +$2.47M | 0.16% | 79 |
|
|
2017
Q1 | $5.5M | Buy |
+338,500
| New | +$5.5M | 0.13% | 100 |
|